acetylcysteine has been researched along with phosphoramidon in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ancolio, K; Checler, F; da Costa, CA | 1 |
Asayama, K; Dobashi, K; Orak, JK; Singh, AK; Singh, I | 1 |
Giri, S; Mehta, A; Orak, JK; Sekhon, CP; Singh, AK | 1 |
3 other study(ies) available for acetylcysteine and phosphoramidon
Article | Year |
---|---|
C-terminal maturation fragments of presenilin 1 and 2 control secretion of APP alpha and A beta by human cells and are degraded by proteasome.
Topics: Acetylcysteine; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Glycopeptides; Humans; Leucine; Leupeptins; Membrane Proteins; Multienzyme Complexes; Oligopeptides; Pepstatins; Presenilin-1; Presenilin-2; Proteasome Endopeptidase Complex; Recombinant Proteins; Sulfones; Transfection | 1999 |
Combination therapy of N-acetylcysteine, sodium nitroprusside and phosphoramidon attenuates ischemia-reperfusion injury in rat kidney.
Topics: Acetylcysteine; Animals; Antioxidants; Catalase; Disease Models, Animal; Drug Therapy, Combination; Glutathione Peroxidase; Glycopeptides; Ischemic Preconditioning; Kidney; Male; Nitroprusside; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase; Time Factors | 2002 |
Attenuation of ischemia/reperfusion induced MAP kinases by N-acetyl cysteine, sodium nitroprusside and phosphoramidon.
Topics: Acetylcysteine; Animals; Disease Models, Animal; Glycopeptides; Immunohistochemistry; Ischemia; Ischemic Preconditioning; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Nitroprusside; Phosphorylation; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Survival Rate; Time Factors; Transcription Factor AP-1 | 2002 |